Accreditation Statistics

As of May 2, 2024

Cellular Therapy Entities

  • Accredited: 262
  • Applicants: 30

Cord Blood Banks

  • Accredited: 48
  • Applicants: 10


Initial Accreditations

  • Abu Dhabi Stem Cell Center, Abu Dhabi, United Arab Emirates | Cellular Therapy Product Processing with Minimal Manipulation
  • CHN - Complexo Hospitalar de Niterói, Rio de Janeiro, Brazil | Adult and Pediatric Allogeneic and Autologous Hematopoietic Progenitor Cell Transplantation, Marrow and  Peripheral Blood Cellular Therapy Product Collection, and Cellular Therapy Product Processing with Minimal Manipulation


A complete list of accredited organizations can be found at

Cord Blood Association Provides Listing of Peer Reviewed Articles Related to Dextran Shortages

Posted in :: 2021 Volume 5 :: Tuesday, October 26th, 2021

Current shortages of Dextran-40 in normal saline may have an impact on cellular therapy programs’ processes for preparing cord blood units for administration to patients. This shortage is expected to last until April 2022. To assist programs, the Cord Blood Association (CBA) provided some alternatives in a bulletin titled, Transplant Centers Report Dextran Shortage. The bulletin also includes a list of peer-reviewed articles published during a similar shortage in 2015. These articles are:

If your program uses Dextran-40 but switches to an alternative, the material must be qualified and validated or verified to produce expected results within your processes.